Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APPTg2576 mouse model of Alzheimer’s disease
- 1 January 2011
- journal article
- research article
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 95 (1) , 64-72
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in ratsNeuropharmacology, 2010
- Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibitionBehavioural Brain Research, 2009
- Effects of the H3 antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in ratsPsychopharmacology, 2009
- Behavioral consequences of ovarian atrophy and estrogen replacement in the APPswe mouseNeurobiology of Aging, 2008
- Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal functionNeuropharmacology, 2008
- Corticosterone and related receptor expression are associated with increased β-amyloid plaques in isolated Tg2576 miceNeuroscience, 2008
- One‐year longitudinal evaluation of sensorimotor functions in APP751SL transgenic miceGenes, Brain and Behavior, 2008
- GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical ModelsThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Spatial relationship between synapse loss and β‐amyloid deposition in Tg2576 miceJournal of Comparative Neurology, 2006
- Hippocampal Theta Oscillations and Classical ConditioningNeurobiology of Learning and Memory, 2001